Prognostic Significance of Dual-Specificity Phosphatase 23 Expression in Acute Myeloid Leukemia

References

• Gu Y, Chu M-Q, Xu Z-J, et al. Comprehensive analysis of SPAG1 expression as a prognostic and predictive biomarker in acute myeloid leukemia by integrative bioinformatics and clinical validation. BMC Med Genomics. 2022;15(1):38. doi:10.1186/s12920-022-01193-0
   PubMed Web of Science ®Google Scholar
• Li G, Gao Y, Li K, Lin A, Jiang Z. Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia. Oncol Lett. 2020;20(2):1824–1834. doi:10.3892/ol.2020.11700
   PubMed Web of Science ®Google Scholar
• Chen S, Wang C, Zhu R, Zhu S, Zhang G. Predicting prognosis in acute myeloid leukemia patients by surface-enhanced Raman spectroscopy. Nanomedicine. 2021;16(21):1873–1885. doi:10.2217/nnm-2021-0199
   PubMed Web of Science ®Google Scholar
• Li F, Ling Q, Lian J, et al. Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. Cancer Med. 2023;12(7):8319–8330. doi:10.1002/cam4.5531
   PubMed Web of Science ®Google Scholar
• Li F, Ling Q, Hu C, et al. Characterization of the Newly Established Homoharringtonine- (HHT-) resistant cell lines and mechanisms of resistance. J Oncol. 2022;2022:2813938. doi:10.1155/2022/2813938
   PubMedGoogle Scholar
• Moser KL, Neas BR, Salmon JE, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci U S A. 1998;95(25):14869–14874. doi:10.1073/pnas.95.25.14869
   PubMed Web of Science ®Google Scholar
• Wu Q, Li Y, Gu S, et al. Molecular cloning and characterization of a novel dual-specificity phosphatase 23 gene from human fetal brain. Int J Biochem Cell Biol. 2004;36(8):1542–1553. doi:10.1016/j.biocel.2003.12.014
   PubMed Web of Science ®Google Scholar
• Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
   PubMed Web of Science ®Google Scholar
• Li K, Luo H, Luo H, Zhu X. Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors. Aging. 2020;12(23):23931–23944. doi:10.18632/aging.104064
   PubMedGoogle Scholar
• Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678. doi:10.1038/s41587-020-0546-8
   PubMed Web of Science ®Google Scholar
• Wang J-D, Zhou H-S, Tu X-X, et al. Prediction of competing endogenous RNA coexpression network as prognostic markers in AML. Aging. 2019;11(10):3333–3347. doi:10.18632/aging.101985
   PubMedGoogle Scholar
• Zhuang H, Li F, Si T, et al. High expression of CD300A predicts poor survival in acute myeloid leukemia. Acta Haematol. 2023;146(3):196–205. doi:10.1159/000529078
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Wouters BJ, Erpelinck CA, et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 2009;94(1):131–134. doi:10.3324/haematol.13299
   PubMed Web of Science ®Google Scholar
• de Jonge HJ, Valk PJ, Veeger NJ, et al. High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia. Blood. 2010;116(10):1747–1754. doi:10.1182/blood-2010-03-270991
   PubMed Web of Science ®Google Scholar
• Zhou T, Cai Z, Ma N, et al. A novel ten-gene signature predicting prognosis in hepatocellular carcinoma. Front Cell Dev Biol. 2020;8:629. doi:10.3389/fcell.2020.00629
   PubMed Web of Science ®Google Scholar
• Infante MS, Piris M, Hernández-Rivas J. Alteraciones moleculares en leucemia mieloide aguda y sus implicaciones clínicas y terapéuticas [Molecular alterations in acute myeloid leukemia and their clinical and therapeutical implications]. Med Clin. 2018;151(9):362–367. Spanish. doi:10.1016/j.medcli.2018.05.002
   PubMed Web of Science ®Google Scholar
• Grimwade D, Jovanovic JV, Hills RK, et al. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy. J Clin Oncol. 2009;27(22):3650–3658. doi:10.1200/jco.2008.20.1533
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416.e11. doi:10.1016/j.cell.2018.02.052
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi:10.1093/bioinformatics/btp616
   PubMed Web of Science ®Google Scholar
• Rosenthal R, Cadieux EL, Salgado R, et al. Neoantigen-directed immune escape in lung cancer evolution. Nature. 2019;567:7749):479–485. doi:10.1038/s41586-019-1032-7
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100(5):1532–1542. doi:10.1182/blood-2002-02-0492
   PubMed Web of Science ®Google Scholar
• Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene. 2007;26(22):3100–3112. doi:10.1038/sj.onc.1210392
   PubMed Web of Science ®Google Scholar
• Geest CR, Coffer PJ. MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol. 2009;86(2):237–250. doi:10.1189/jlb.0209097
   PubMed Web of Science ®Google Scholar
• Soleimani A, Rahmani F, Saeedi N, et al. The potential role of regulatory microRNAs of RAS/MAPK signaling pathway in the pathogenesis of colorectal cancer. J Cell Biochem. 2019;120(12):19245–19253. doi:10.1002/jcb.29268
   PubMed Web of Science ®Google Scholar
• Long X, Song K, Hu H, et al. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis. J Exp Clin Cancer Res. 2019;38(1):345. doi:10.1186/s13046-019-1329-2
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang WK, Wen GM, et al. High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival. Mol Genet Genomic Med. 2019;7(11):e908. doi:10.1002/mgg3.908
   PubMed Web of Science ®Google Scholar
• Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell. 2017;170(1):17–33. doi:10.1016/j.cell.2017.06.009
   PubMed Web of Science ®Google Scholar
• Ratner N, Miller SJ. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015;15(5):290–301. doi:10.1038/nrc3911
   PubMed Web of Science ®Google Scholar
• Martelli AM, Evangelisti C, Chappell W, et al. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia. 2011;25(7):1064–1079. doi:10.1038/leu.2011.46
   PubMed Web of Science ®Google Scholar
• Gruszka AM, Valli D, Alcalay M. Wnt signalling in acute myeloid leukaemia. Cells. 2019;8(11):1403.
   PubMed Web of Science ®Google Scholar
• Chen P, Redd L, Schmidt Y, et al. MYC protein expression does not correlate with MYC abnormalities detected by FISH but predicts an unfavorable prognosis in de novo acute myeloid leukemia. Leuk Res. 2021;106:106584. doi:10.1016/j.leukres.2021.106584
   PubMed Web of Science ®Google Scholar
• Barbosa K, Li S, Adams PD, Deshpande AJ. The role of TP53 in acute myeloid leukemia: challenges and opportunities. Genes Chromosomes Cancer. 2019;58(12):875–888. doi:10.1002/gcc.22796
   PubMed Web of Science ®Google Scholar
• Liao B, Hu Y, Brewer G. RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation. J Biol Chem. 2011;286(36):31145–31152. doi:10.1074/jbc.M111.263913
   PubMed Web of Science ®Google Scholar
• Liao B, Hu Y, Herrick DJ, Brewer G. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem. 2005;280(18):18517–18524. doi:10.1074/jbc.M500270200
   PubMed Web of Science ®Google Scholar
• Fu Q, Hong R, Zhou H, et al. Proteomics reveals MRPL4 as a high-risk factor and a potential diagnostic biomarker for prostate cancer. Proteomics. 2022;22(21):e2200081. doi:10.1002/pmic.202200081
   PubMed Web of Science ®Google Scholar
• Qiu X, Guo D, Du J, Bai Y, Wang F. A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate. Medicine. 2021;100(8):e24898. doi:10.1097/md.0000000000024898
   PubMed Web of Science ®Google Scholar
• Cui X, Li C, Ding J, et al. Establishing a proteomics-based signature of AKR1C3-related genes for predicting the prognosis of prostate cancer. Int J Mol Sci. 2023;24(5):4513.
   PubMed Web of Science ®Google Scholar
• Jin S, Qian Z, Liang T, et al. Identification of a DNA repair-related multigene signature as a novel prognostic predictor of glioblastoma. World Neurosurg. 2018;117:e34–e41. doi:10.1016/j.wneu.2018.05.122
   PubMed Web of Science ®Google Scholar
• Li M, Liu Z, Wang J, et al. Systematic analysis identifies a specific RNA-binding protein-related gene model for prognostication and risk-adjustment in HBV-related hepatocellular carcinoma. Front Genet. 2021;12:707305. doi:10.3389/fgene.2021.707305
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen Z, Xie G, et al. RNA m(1)A methylation regulates glycolysis of cancer cells through modulating ATP5D. Proc Natl Acad Sci U S A. 2022;119(28):e2119038119. doi:10.1073/pnas.2119038119
   PubMed Web of Science ®Google Scholar
• Michel T, Poli A, Cuapio A, et al. Human CD56bright NK cells: an update. J Immunol. 2016;196(7):2923–2931. doi:10.4049/jimmunol.1502570
   PubMed Web of Science ®Google Scholar
• Lima M. Extranodal NK/T cell lymphoma and aggressive NK cell leukaemia: evidence for their origin on CD56+bright CD16-/+dim NK cells. Pathology. 2015;47(6):503–514. doi:10.1097/pat.0000000000000275
   PubMed Web of Science ®Google Scholar